| Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage. | |
| | |
MedLine Citation:
|
PMID: 20877635 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
INTRODUCTION: Chagas disease remains a major cause of mortality in several countries of Latin America and has become a potential public health problem in non-endemic countries as a result of migration flows. Cardiac involvement represents the main cause of mortality, but its diagnosis is still based on nonspecific criteria with poor sensitivity. Early identification of patients with cardiac involvement is desirable, since early treatment may improve prognosis. This study aimed to assess the role of diastolic dysfunction, abnormal myocardial strain and elevated brain natriuretic peptide (BNP) in the early identification of cardiac involvement in Chagas disease. METHODOLOGY/PRINCIPAL FINDINGS: Fifty-four patients divided into 3 groups--group 1 (undetermined form: positive serology without ECG or 2D-echocardiographic abnormalities; N = 32), group 2 (typical ECG abnormalities of Chagas disease but normal 2D-echocardiography; N = 14), and group 3 (regional wall motion abnormalities, left ventricular [LV] end-diastolic diameter >55 mm or LV ejection fraction <50% on echocardiography; N = 8)--and 44 control subjects were studied. Patients with significant non-cardiac diseases, other heart diseases and previous treatment with benznidazol were excluded. The median age was 37 (20-58) years; 40% were men. BNP levels, longitudinal and radial myocardial strain and LV diastolic dysfunction increased progressively from group 1 to 3 (p for trend <0.01). Abnormal BNP levels (>37 pg/ml) were noted in 0%, 13%, 29% and 63% in controls and groups 1 to 3, respectively. Half of patients in the undetermined form had impaired relaxation patterns, whereas half of patients with ECG abnormalities suggestive of Chagas cardiomyopathy had normal diastolic function. In group 1, BNP levels were statistically higher in patients with diastolic dysfunction as compared to those with normal diastolic function (27 ± 26 vs. 11 ± 8 pg/ml, p = 0.03). CONCLUSION/SIGNIFICANCE: In conclusion, the combination of diastolic function and BNP measurement adds important information that could help to better stratify patients with Chagas disease. |
| | |
Authors:
|
Ana Garcia-Alvarez; Marta Sitges; María-Jesús Pinazo; Ander Regueiro-Cueva; Elizabeth Posada; Silvia Poyatos; José Tomás Ortiz-Pérez; Magda Heras; Manel Azqueta; Joaquim Gascon; Ginés Sanz |
Related Documents
:
|
11827925 - Utility of b-natriuretic peptide in detecting diastolic dysfunction: comparison with do... 11767995 - Relationship between cardiac 123i-metaiodobenzylguanidine imaging and the transcardiac ... 17181125 - The use of b-type natriuretic peptide to diagnose congestive heart failure. 19858735 - Long-term effects of b-type natriuretic peptide infusion after acute myocardial infarct... 8473665 - Coupling between regional myocardial oxygen consumption and contraction under altered p... 7570735 - Clinical and prognostic correlates of stroke subtype misdiagnosis within 12 hours from ... |
Publication Detail:
|
Type: Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't Date: 2010-09-21 |
Journal Detail:
|
Title: PLoS neglected tropical diseases Volume: 4 ISSN: 1935-2735 ISO Abbreviation: PLoS Negl Trop Dis Publication Date: 2010 |
Date Detail:
|
Created Date: 2010-09-29 Completed Date: 2010-12-23 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101291488 Medline TA: PLoS Negl Trop Dis Country: United States |
Other Details:
|
Languages: eng Pagination: - Citation Subset: IM |
Affiliation:
|
Thorax Clinic Institute, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Biological Markers Chagas Cardiomyopathy / diagnosis*, physiopathology Diastole / physiology* Early Diagnosis Echocardiography / methods Female Humans Latin America Male Middle Aged Natriuretic Peptide, Brain / blood* Sensitivity and Specificity |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 114471-18-0/Natriuretic Peptide, Brain |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Molecular modeling-based evaluation of hTLR10 and identification of potential ligands in Toll-like r...
Next Document: Additional serine/threonine phosphorylation reduces binding affinity but preserves interface topogra...